1. Home
  2. PFE vs BMY Comparison

PFE vs BMY Comparison

Compare PFE & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pfizer Inc.

PFE

Pfizer Inc.

N/A

Current Price

$27.53

Market Cap

161.2B

Sector

Health Care

ML Signal

N/A

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

N/A

Current Price

$59.02

Market Cap

127.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PFE
BMY
Founded
1849
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.2B
127.0B
IPO Year
2013
2006

Fundamental Metrics

Financial Performance
Metric
PFE
BMY
Price
$27.53
$59.02
Analyst Decision
Hold
Hold
Analyst Count
28
28
Target Price
$30.22
★ $65.25
AVG Volume (30 Days)
★ 24.3M
9.0M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
★ 6.25%
4.32%
EPS Growth
N/A
★ 178.46
EPS
0.99
★ 3.98
Revenue
★ $62,579,000,000.00
$48,194,000,000.00
Revenue This Year
$0.88
$4.23
Revenue Next Year
N/A
N/A
P/E Ratio
$27.85
★ $14.66
Revenue Growth
N/A
★ N/A
52 Week Low
$23.62
$47.58
52 Week High
$31.44
$68.64

Technical Indicators

Market Signals
Indicator
PFE
BMY
Relative Strength Index (RSI) 34.06 39.40
Support Level $26.68 $55.66
Resistance Level $27.75 $60.93
Average True Range (ATR) 0.70 1.71
MACD -0.31 -0.46
Stochastic Oscillator 1.25 13.93

Price Performance

Historical Comparison
PFE
BMY

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: